Morgan G W, Breit S N
Department of Radiation Oncology, St. Vincent's Hospital, Sydney, NSW, Australia.
Int J Radiat Oncol Biol Phys. 1995 Jan 15;31(2):361-9. doi: 10.1016/0360-3016(94)00477-3.
Recent data from several investigators, including our unit, have provided additional information on the etiology of radiation-induced lung damage. These data suggest that there are two quite separate and distinct mechanisms involved: (a) classical radiation pneumonitis, which ultimately leads to pulmonary fibrosis is primarily due to radiation-induced local cytokine production confined to the field of irradiation; and (b) sporadic radiation pneumonitis, which is an immunologically mediated process resulting in a bilateral lymphocytic alveolitis that results in an "out-of-field" response to localized pulmonary irradiation. Both animal experiments and human studies show that classical radiation pneumonitis has a threshold dose and a narrow sigmoid dose-response curve with increasing morbidity and mortality over a very small dose range. Clinical pneumonitis rarely causes death, whereas in the animal and human studies of classical radiation pneumonitis, all subjects will eventually suffer irreversible pulmonary damage and death. The description of classical radiation pneumonitis is that of an acute inflammatory response to lung irradiation, which is confined to the area of irradiation. Recent studies have also shown that irradiation induces gene transcription and results in the induction and release of proinflammatory cytokines and fibroblast mitogens in a similar fashion to other chronic inflammatory states, and which ultimately results in pulmonary fibrosis. The description of classical radiation pneumonitis does not adequately explain the following observed clinical characteristics: (a) the unpredictable and sporadic onset; (b) the occurrence in only a minority of patients; (c) the dyspnoea experienced, which is out of proportion to the volume of lung irradiated; and (d) the resolution of symptoms without sequelae in the majority of patients. We have demonstrated a bilateral lymphocytic alveolitis of activated T lymphocytes and a diffuse increase in gallium lung scan uptake in patients studied before and 4 to 6 weeks after strictly unilateral lung irradiation. This is suggestive of a hypersensitivity pneumonitis, which gives rise to an "out-of-field" response to localized lung irradiation and hence more accurately describes the clinical picture of radiation pneumonitis. Reevaluation of the mechanisms of pulmonary injury from irradiation suggest that (a) a new term, sporadic radiation pneumonitis, should be introduced to describe the clinical picture of radiation pneumonitis, which is not adequately explained by the classical description and is quite clearly an entirely different process; and (b) that the chronic response to localized lung irradiation that leads to pulmonary fibrosis is largely mediated through the induction and release of tissues cytokines.
包括我们团队在内的几位研究者近期提供了有关放射性肺损伤病因的更多信息。这些数据表明,其中涉及两种截然不同的机制:(a) 典型放射性肺炎,最终导致肺纤维化,主要是由于局限于照射野内的辐射诱导局部细胞因子产生;(b) 散发性放射性肺炎,这是一种免疫介导的过程,导致双侧淋巴细胞性肺泡炎,从而引发对局部肺部照射的“野外”反应。动物实验和人体研究均表明,典型放射性肺炎有一个阈值剂量,且剂量反应曲线呈狭窄的S形,在非常小的剂量范围内发病率和死亡率都会增加。临床肺炎很少导致死亡,而在典型放射性肺炎的动物和人体研究中,所有受试者最终都会遭受不可逆转的肺损伤和死亡。典型放射性肺炎的描述是对肺部照射的急性炎症反应,局限于照射区域。近期研究还表明,照射会诱导基因转录,并以与其他慢性炎症状态类似的方式导致促炎细胞因子和成纤维细胞有丝分裂原的诱导和释放,最终导致肺纤维化。典型放射性肺炎的描述无法充分解释以下观察到的临床特征:(a) 不可预测和散发性发作;(b) 仅在少数患者中发生;(c) 所经历的呼吸困难与照射的肺体积不成比例;(d) 大多数患者症状缓解且无后遗症。我们在严格单侧肺部照射前及照射后4至6周对患者进行研究,发现活化T淋巴细胞的双侧淋巴细胞性肺泡炎以及镓肺扫描摄取量弥漫性增加。这提示存在过敏性肺炎,它会引发对局部肺部照射的“野外”反应,从而更准确地描述放射性肺炎的临床情况。对辐射所致肺损伤机制的重新评估表明:(a) 应引入一个新术语“散发性放射性肺炎”来描述放射性肺炎的临床情况,这无法用经典描述充分解释,且显然是一个完全不同的过程;(b) 导致肺纤维化的对局部肺部照射的慢性反应很大程度上是通过组织细胞因子的诱导和释放介导的。